RT Journal Article
SR Electronic
T1 Quality Indicators and Survival Outcome in Stage IIIB-IVB Epithelial Ovarian Cancer Treated at a Single Institution
JF In Vivo
JO In Vivo
FD International Institute of Anticancer Research
SP 1521
OP 1530
DO 10.21873/invivo.11632
VO 33
IS 5
A1 INGA STEINBERGA
A1 KJELL JANSSON
A1 BENGT SORBE
YR 2019
UL http://iv.iiarjournals.org/content/33/5/1521.abstract
AB Background/Aim: To investigate the overall survival rate, quality indicators and treatment outcome in FIGO stage IIIB-IVB epithelial ovarian cancer at a University Hospital in Sweden between 2006 and 2015. Materials and Methods: A cohort of 110 patients was followed-up for 3-12 years after cancer diagnosis. Three main groups (primary surgery, neoadjuvant chemotherapy, palliative treatment), and six subgroups were defined according to treatment modality. Results: The mean age was 65 years. Patients were observed for a mean of 50 months. The total resection frequency was 83%. Significant differences in overall survival at 5 years were observed between the groups varying from 60% to 12%. Conclusion: Patient age, tumor stage and complete tumor removal at surgery were significant, independent prognostic factors of overall survival. Complication rate was a significant adverse prognostic factor in univariate analysis. Data discrepancy was observed between public quality reports and locally obtained data.